Pieter Meysman
Associate professor
University of Antwerp
Antwerp, Belgium
Associate professor in biomedical data science research at the University of Antwerp, Belgium at the ADREM data lab
About me
Prof. dr. ir. Pieter Meysman is associate professor at the University of Antwerp, Belgium at the ADREM data lab and leads the immunoinformatics activities of the AUDACIS consortium. He graduated as a PhD in bioscience engineering from the KULeuven in 2012, and has published more than 90 research articles and patents. His research has directly resulted in two university spin-offs of the University of Antwerp and Antwerp University Hospital, namely Innocens and ImmuneWatch. He is active in the latter as the part-time CTO to oversee technology transfer from the university to ImmuneWatch.
His main research focus is on the use of artificial intelligence to gain understanding into the adaptive immune system. To this end, he has supervised the development of several immunoinformatics tools to handle complex immunological data, including TCRex, ClusTCR and ImRex. He has won a number of awards for his research into the human T-cell receptor repertoire, including the GSK Vaccines award.
My organisation
The University of Antwerp (Dutch: Universiteit Antwerpen) is a major Belgian university located in the city of Antwerp. The University of Antwerp has about 20,000 students, which makes it the third-largest university in Flanders. The University of Antwerp is characterised by its high standards in education, internationally competitive research and entrepreneurial approach.
Additional questions
How would you categorise yourself?
Organisation Type
Areas of expertise
Therapeutic areas
1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.
I agreeSpeaker sessions (1)
Thursday, 17 October 2024
10:35 - 11:00
Revealing vaccine-induced T-cell responses using Artificial Intelligence – Pieter Meysman, Antwerp University
The vaccine-mediated immune response is a complex system mediated by a combination of different cell types. In this talk, I will discuss how we are using artificial intelligence to help us understand how and why people respond to vaccines the way they do.